SP1 and lung carcinoma: Analysis of damage patterns at CCCTC-binding factor and SP1 transcription factor binding sites indicates that BPDE damage formation is also suppressed by these DNA-bound proteins, and this damage modulation correlates with mutation patterns at these binding sites in lung cancers.